Antibiotic resistance: The Iowa Experience

American Journal of Managed Care

Volumn 8, Issue 11, 2002, Pages 988-994

  Bell, Nancy ^a  

^a Iowa Soybean Association   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFTRIAXONE; CEFUROXIME AXETIL; CEPHALOSPORIN; CHLORAMPHENICOL; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; METICILLIN; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; DRUG COST; DRUG USE; HEALTH CARE PLANNING; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INFECTION; INFECTION CONTROL; INTERNET; MEDICAL INFORMATION; PENICILLIN RESISTANCE; PREFERRED PROVIDER ORGANIZATION; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE; DRUG UTILIZATION; EDUCATION, MEDICAL, CONTINUING; ENTEROCOCCUS; HEALTH SERVICES MISUSE; HUMANS; IOWA; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; PRACTICE GUIDELINES; PUBLIC HEALTH PRACTICE; SENTINEL SURVEILLANCE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; TEACHING MATERIALS;

EID: 0036858407     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. World Health Organization. Drug resistance threatens to reverse medical progress. Available at: http://www.who.int.inf-pr-2000/en/pr2000-41.html. Accessed February 13, 2001.
2. Jacobs MR. Emergence of antibiotic resistance in upper and lower respiratory tract infections. Am J Manag Care. 1999;5(suppl):S651-S661.
3. Jacobs MR, Bajaksouzian S, Zilles A, et al. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. surveillance study. Antimicrob Agents Chemother. 1999;43:1901-1908.
4. Kelley MA, Weber DJ, Gilligan P, Cohen MS. Breaktrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clin Infect Dis. 2000;31:1008-1011.
5. Garau J, Lonks JR, Gomez L, Xercavins M, Medeiros AA. Failure of macrolide therapy in patients with bacteremia due to macrolide-resistant Streptococcus pneumoniae. Poster presented at: International Conference on the Macrolides, Azalides and Streptogramins (ICMAS-KO5); January 26-27, 2000; Seville, Spain. Abstract 7.09. Available at: http://www.icmask.org/icmasko5/search/7.09.shtml. Accessed January 8, 2001.
6. Dagan R, Leibovitz E, Fliss DM, et al. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob Agents Chemother. 2000;44:43-50.
7. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care clinicians. JAMA. 1997;278:901-904.
8. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: Management and surveillance in an era of pneumococcal resistance - A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 1999;18:1-9.
9. Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2000;123(suppl):S1-S32.
10. Jernigan DB, Cetron MS, Breiman RF. Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP): A strategy from the DRSP Working Group. JAMA. 1996;275:206-209.
11. Bowersox NK. Combatting antibiotic resistance. DUR Digest. Fall 1999:12(1).